The Longitudinal Adjusted Associations of Participant Characteristics With FEV1 <80% Predicted and FVC <80% Predicted Using the Fixed Ratio Definitiona
Overall . | FEV1 <80% Predicted vs Normal aOR (95% CI) . | P Value . | FVC <80% Predicted vs Normal aOR (95% CI) . | P Value . |
---|---|---|---|---|
nparticipants = 358; nobs = 617 . | nparticipants = 341; nobs = 575 . | |||
Age >32 y | 1.34 (0.85–2.11) | .21 | 1.16 (0.72–1.89) | .54 |
Female sex | 1.68 (1.05–2.69) | .03 | 1.53 (0.93–2.50) | .09 |
BMI, tertile 2 vs 1b | 0.60 (0.41–0.87) | .01 | 0.48 (0.33–0.69) | <.001 |
BMI, tertile 3 vs 1 | 0.33 (0.21–0.54) | <.001 | 0.25 (0.16–0.41) | <.001 |
Ptrend | … | <.001 | … | <.001 |
Ever cigarette smoker | 1.49 (0.82–2.72) | .19 | 1.32 (0.69–2.49) | .40 |
Exposure to biomass fuel at home | 0.87 (0.51–1.47) | .59 | 0.75 (0.44–1.29) | .31 |
HIV+ vs HIV- | 0.50 (0.30–0.83) | .01 | 0.58 (0.33–0.94) | .03 |
TB+ vs TB- | 0.54 (0.29–1.00) | .05 | 0.75 (0.38–1.49) | .41 |
HIV+ | nparticipants = 137; nobs = 239 | nparticipants = 130; nobs = 221 | ||
Female sex | 3.20 (1.39–7.36) | .006 | 3.20 (1.26–8.13) | .02 |
HIV- | nparticipants = 221; nobs = 378 | nparticipants = 211; nobs = 354 | ||
Female sex | 1.26 (0.72–2.23) | .42 | 1.23 (0.68–2.25) | .49 |
Overall . | FEV1 <80% Predicted vs Normal aOR (95% CI) . | P Value . | FVC <80% Predicted vs Normal aOR (95% CI) . | P Value . |
---|---|---|---|---|
nparticipants = 358; nobs = 617 . | nparticipants = 341; nobs = 575 . | |||
Age >32 y | 1.34 (0.85–2.11) | .21 | 1.16 (0.72–1.89) | .54 |
Female sex | 1.68 (1.05–2.69) | .03 | 1.53 (0.93–2.50) | .09 |
BMI, tertile 2 vs 1b | 0.60 (0.41–0.87) | .01 | 0.48 (0.33–0.69) | <.001 |
BMI, tertile 3 vs 1 | 0.33 (0.21–0.54) | <.001 | 0.25 (0.16–0.41) | <.001 |
Ptrend | … | <.001 | … | <.001 |
Ever cigarette smoker | 1.49 (0.82–2.72) | .19 | 1.32 (0.69–2.49) | .40 |
Exposure to biomass fuel at home | 0.87 (0.51–1.47) | .59 | 0.75 (0.44–1.29) | .31 |
HIV+ vs HIV- | 0.50 (0.30–0.83) | .01 | 0.58 (0.33–0.94) | .03 |
TB+ vs TB- | 0.54 (0.29–1.00) | .05 | 0.75 (0.38–1.49) | .41 |
HIV+ | nparticipants = 137; nobs = 239 | nparticipants = 130; nobs = 221 | ||
Female sex | 3.20 (1.39–7.36) | .006 | 3.20 (1.26–8.13) | .02 |
HIV- | nparticipants = 221; nobs = 378 | nparticipants = 211; nobs = 354 | ||
Female sex | 1.26 (0.72–2.23) | .42 | 1.23 (0.68–2.25) | .49 |
nparticipants = the number of participants included in the analysis; nobs = the number of unique observations included in the analysis. The bold values are those that reached statistical significance.
Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; FEV1%predicted, forced expiratory volume in 1 second as percentage of predicted reference value; FVC% predicted, forced vital capacity as percentage of predicted reference value; TB, tuberculosis.
aAdjusted for age, BMI, smoking status, biomass fuel exposure, HIV, and TB status.
bBMI was divided into tertiles to facilitate model convergence. For clinical interpretation, trend was also assessed.
The Longitudinal Adjusted Associations of Participant Characteristics With FEV1 <80% Predicted and FVC <80% Predicted Using the Fixed Ratio Definitiona
Overall . | FEV1 <80% Predicted vs Normal aOR (95% CI) . | P Value . | FVC <80% Predicted vs Normal aOR (95% CI) . | P Value . |
---|---|---|---|---|
nparticipants = 358; nobs = 617 . | nparticipants = 341; nobs = 575 . | |||
Age >32 y | 1.34 (0.85–2.11) | .21 | 1.16 (0.72–1.89) | .54 |
Female sex | 1.68 (1.05–2.69) | .03 | 1.53 (0.93–2.50) | .09 |
BMI, tertile 2 vs 1b | 0.60 (0.41–0.87) | .01 | 0.48 (0.33–0.69) | <.001 |
BMI, tertile 3 vs 1 | 0.33 (0.21–0.54) | <.001 | 0.25 (0.16–0.41) | <.001 |
Ptrend | … | <.001 | … | <.001 |
Ever cigarette smoker | 1.49 (0.82–2.72) | .19 | 1.32 (0.69–2.49) | .40 |
Exposure to biomass fuel at home | 0.87 (0.51–1.47) | .59 | 0.75 (0.44–1.29) | .31 |
HIV+ vs HIV- | 0.50 (0.30–0.83) | .01 | 0.58 (0.33–0.94) | .03 |
TB+ vs TB- | 0.54 (0.29–1.00) | .05 | 0.75 (0.38–1.49) | .41 |
HIV+ | nparticipants = 137; nobs = 239 | nparticipants = 130; nobs = 221 | ||
Female sex | 3.20 (1.39–7.36) | .006 | 3.20 (1.26–8.13) | .02 |
HIV- | nparticipants = 221; nobs = 378 | nparticipants = 211; nobs = 354 | ||
Female sex | 1.26 (0.72–2.23) | .42 | 1.23 (0.68–2.25) | .49 |
Overall . | FEV1 <80% Predicted vs Normal aOR (95% CI) . | P Value . | FVC <80% Predicted vs Normal aOR (95% CI) . | P Value . |
---|---|---|---|---|
nparticipants = 358; nobs = 617 . | nparticipants = 341; nobs = 575 . | |||
Age >32 y | 1.34 (0.85–2.11) | .21 | 1.16 (0.72–1.89) | .54 |
Female sex | 1.68 (1.05–2.69) | .03 | 1.53 (0.93–2.50) | .09 |
BMI, tertile 2 vs 1b | 0.60 (0.41–0.87) | .01 | 0.48 (0.33–0.69) | <.001 |
BMI, tertile 3 vs 1 | 0.33 (0.21–0.54) | <.001 | 0.25 (0.16–0.41) | <.001 |
Ptrend | … | <.001 | … | <.001 |
Ever cigarette smoker | 1.49 (0.82–2.72) | .19 | 1.32 (0.69–2.49) | .40 |
Exposure to biomass fuel at home | 0.87 (0.51–1.47) | .59 | 0.75 (0.44–1.29) | .31 |
HIV+ vs HIV- | 0.50 (0.30–0.83) | .01 | 0.58 (0.33–0.94) | .03 |
TB+ vs TB- | 0.54 (0.29–1.00) | .05 | 0.75 (0.38–1.49) | .41 |
HIV+ | nparticipants = 137; nobs = 239 | nparticipants = 130; nobs = 221 | ||
Female sex | 3.20 (1.39–7.36) | .006 | 3.20 (1.26–8.13) | .02 |
HIV- | nparticipants = 221; nobs = 378 | nparticipants = 211; nobs = 354 | ||
Female sex | 1.26 (0.72–2.23) | .42 | 1.23 (0.68–2.25) | .49 |
nparticipants = the number of participants included in the analysis; nobs = the number of unique observations included in the analysis. The bold values are those that reached statistical significance.
Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; FEV1%predicted, forced expiratory volume in 1 second as percentage of predicted reference value; FVC% predicted, forced vital capacity as percentage of predicted reference value; TB, tuberculosis.
aAdjusted for age, BMI, smoking status, biomass fuel exposure, HIV, and TB status.
bBMI was divided into tertiles to facilitate model convergence. For clinical interpretation, trend was also assessed.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.